- Home
- GPOR vs ACLX Comparison
GPOR vs ACLX Comparison
Compare GPOR & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPOR | ACLX |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GPOR | ACLX |
|---|---|---|
| Price | $174.62 | $66.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $229.78 | $113.75 |
| AVG Volume (30 Days) | 236.9K | ★ 919.4K |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,231,668,000.00 | $35,898,000.00 |
| Revenue This Year | $57.83 | N/A |
| Revenue Next Year | $9.48 | $293.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 38.91 | N/A |
| 52 Week Low | $153.27 | $47.86 |
| 52 Week High | $225.78 | $94.07 |
Technical Indicators
Market Signals| Indicator | GPOR | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 25.96 | 46.80 |
| Support Level | $198.83 | $60.36 |
| Resistance Level | $217.17 | $66.08 |
| Average True Range (ATR) | 5.70 | 2.10 |
| MACD | -3.72 | 0.71 |
| Stochastic Oscillator | 1.14 | 98.45 |
Price Performance
Historical ComparisonAbout GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.